Please select and order
€120.67
excl. VAT
CONFIGURE NOW
Norm
ÖNORM EN ISO 18362
Issue date: 2018 11 15
Manufacture of cell-based health care products - Control of microbial risks during processing (ISO 18362:2016)
This International Standard specifies the minimum requirements for, and provides guidance on, a risk-based approach for the processing of cell-based health care products ...
Read more
Valid
Publisher:
Austrian Standards International
Format:
Digital | 48 Pages
Language:
German
| English
| Download GER/ENG
Optionally co-design standards:
ICS
This International Standard specifies the minimum requirements for, and provides guidance on, a risk-based approach for the processing of cell-based health care products (CBHPs) requiring control of viable and non-viable microbial contamination. It is applicable both to CBHPs labelled ‘sterile’ and to CBHPs not labelled ‘sterile’.
This International Standard is not applicable to:
— procurement and transport of cell-based starting material used in processing of a CBHP,
— cell banking,
— control of genetic material,
— control of non-microbial product contamination,
— in vitro diagnostics (IVDs), or
— natural medicines.
This International Standard does not define biosafety containment requirements.
This International Standard does not replace national or regional regulations that apply to the manufacture and quality control of a CBHP.